期刊文献+

孕中期血清sFlt-1、PIGF和补体系统激活因子对子痫前期危险因素孕妇发生子痫前期的预测价值 被引量:18

Predictive value of serum sFlt-1,PIGF and omplement system activators for preeclampsia in the second trimester pregnant women with preeclampsia risk factors
原文传递
导出
摘要 目的评价孕中期可溶性胎盘血管内皮生长因子受体-1(sFlt-1)、胎盘生长因子(PIGF)、sFlt-1/PIGF比值及补体系统激活因子对子痫前期危险因素孕妇发生子痫前期的预测价值。方法采用病例对照研究。研究组包括165例至少具有一项子痫前期危险因素的孕妇,收集其孕20~26周之间的血清标本,采用酶联免疫吸附试验和免疫透射比浊法检测血清中的sFlt-1、PIGF、C3和B因子,计算s Flt-1/PIGF比值,绘制受试者工作特征(ROC)曲线。结果子痫前期患病组与未患病组相比,s Flt-1、sFlt-1/PIGF、C3、B因子显著升高(均P<0.01),PIGF水平降低(P<0.001)。s Flt-1、PIGF、sFlt-1/PIGF、C3和B因子的ROC曲线下面积分别为0.663、0.770、0.786、0.644、0.690,其中sFlt-1/PIGF的cut-off值为3.3(灵敏度85.7%,特异性77.0%)。结论子痫前期危险因素孕妇的外周循环中存在sFlt-1、PIGF、sFlt-1/PIGF变化和补体系统异常激活,对发生子痫前期有预测价值,且sFlt-1/PIGF表现最佳。 Objective To evaluate the predictive value of soluble placental vascular endothelial growth factor receptor-1(sFlt-1),placental growth factor(PIGF),sflt-1/PIGF ratio and complement system activation factor for preeclampsia risk factors in pregnant women.Methods A case-control study was conducted.The study group included 165 pregnant women with at least one preeclampsia risk factor.Serum samples were collected between 20 to 26 weeks of gestation.Serum sflt-1,PIGF,C3 and B factors were detected by Elisa and immunotransmission turbidimetry.Results sflt-1,sflt-1/PIGF,C3 and B factors were significantly increased in the preeclampsia group(all P<0.01)and decreased in the PIGF group(P<0.001).The areas under the ROC curve of sflt-1,PIGF,sflt-1/PIGF,C3,and B factor were 0.663,0.770,0.786,0.644,and 0.690,respectively.The cut-off value of sflt-1/PIGF was 3.3(sensitivity 85.7%,specificity 77.0%).Conclusion sFlt-1,PIGF,sflt-1/PIGF changes and abnormal complement system activation in the peripheral circulation have predictive value for the occurrence of preeclampsia in pregnant women with preeclampsia risk factors,and sflt-1/PIGF is the best index.
作者 孙文苑 马利娟 吴思沂 贾珂珂 李淑芳 王妍 SUN Wenyuan;MA Lijuan;WU Siyi;JIA Keke;LI Shufang;WANG Yan(Department of Obstetrics and Gynecology,Peking University Third Hospital,Beijing 100191,China)
出处 《中国妇产科临床杂志》 CSCD 北大核心 2020年第5期489-491,共3页 Chinese Journal of Clinical Obstetrics and Gynecology
基金 北京大学第三医院临床重点项目青年项目(Y76439-01)。
关键词 子痫前期 可溶性胎盘血管内皮生长因子受体-1 胎盘生长因子 补体系统激活因子 子痫前期危险因素 preeclampsia solublefms-like tyrosine kinase-1 placental growth factor complement system activator preeclampsia risk factors
  • 相关文献

参考文献2

二级参考文献57

  • 1杨孜,王伽略,黄萍,石凌懿,李蓉,叶蓉华,陈蕾.重度子癎前期终末器官受累不平行性及其围产结局探讨[J].中华围产医学杂志,2006,9(1):10-14. 被引量:109
  • 2Wright JD, Pawar N, Gonzalez JS, et al. Scientific evidence un- derlying the American College of Obstetricians and Gynecolo- gists practice bulletins[J]. Obstet Gynecol, 2011, 118(3):505- 512.
  • 3Perfetto P, Siddiqui D, Niederhauser A, et al. American College of Obstetricians and Gynecologists Practice Bulletins: original versus revised[J]. Am J Perinatol, 2010,27(8): 611-618.
  • 4Bramham K, Nelson-Piercy C, Brown MJ, et al. Postpartum man- agement of hypertension[J]. BMJ, 2013,346(25):f894.
  • 5ACOG Committee on Obstetric Practice. Committee Opinion No. 623: Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period[J]. Obstet Gynecol, 2015,125(2) : 521-525.
  • 6Lowe SA, Brown MA, Dekker GA, et al. Guidelines for the man- agement of hypertensive disorders of pregnancy 2008[J]. Aust N Z J Obstet Gynaecol, 2009,49(3) : 242-246.
  • 7Magee LA, Helewa M, Moutquin JM, et al. Diagnosis, evalua- tion, and management of the hypertensive disorders of pregnan- cy [J]. J Obstet Gynaecol Can, 2008,30(3 Suppl) : S1-S48.
  • 8American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnan- cy. Report of the American College of Obstetricians and Gyne- cologists' Task Force on hypertension in pregnancy[J]. Obstet Gynecol, 2013,122(5): 1122-1131.
  • 9Lowe SA, Bowyer L, Lust K, et al. The SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014 [J]. Aust N Z J Obstet Gynaecol,2015,55(1): 11-16.
  • 10Magee LA, Pels A, Helewa M, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy : exec-utive summary[J]. J Obstet Gynaecol Can, 2014, 36(5): 416-441.

共引文献468

同被引文献159

引证文献18

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部